Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592202 · ClinicalTrials.gov registry record · NA
Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents
A NA study of Morbid Obesity, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT00592202: Completed NA study of Morbid Obesity, sponsored by University of Illinois at Chicago.
NCT00592202 is a NA study of Morbid Obesity that has completed, run by University of Illinois at Chicago. The registered enrollment target is 37 participants, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592202, a NA study of Morbid Obesity, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the LAP-BAND system is safe and effective in morbidly obese adolescents.
Conditions Studied
Interventions
- DEVICE Placement of an adjustable gastric band
Study Locations (1)
Illinois
- UIMC - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2004-12 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT00592202 record still lists
NCT00592202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which Placement of an adjustable gastric band is the first listed.
NCT00592202 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00592202 about?
NCT00592202 is a clinical study titled "Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents". The purpose of this study is to determine whether the LAP-BAND system is safe and effective in morbidly obese adolescents.
What is the current status of trial NCT00592202?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2004-12. Estimated completion is 2013-02.
What conditions does trial NCT00592202 study?
This clinical trial studies the following conditions: Morbid Obesity.
What interventions are being tested in trial NCT00592202?
The interventions under investigation include: Placement of an adjustable gastric band (DEVICE).
Who is sponsoring clinical trial NCT00592202?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592202 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00592202's enrollment target sits among peer trials
37 21st of 24 higher than 4 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Activity Level Monitoring Study
ACTIVE NOT RECRUITING · NA
-
Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates
COMPLETED · NA
-
Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
COMPLETED · NA
-
Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women
COMPLETED · NA
-
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia